M. Buchmeier and T. Lane, Viral-induced neurodegenerative disease, Current Opinion in Microbiology, vol.2, issue.4, pp.398-402, 1999.
DOI : 10.1016/S1369-5274(99)80070-8

P. Talbot, H. Jacomy, and M. Desforges, Pathogenesis of human coronaviruses other than severe acute respiratory syndrome coronavirus The nidoviruses, pp.313-324, 2008.

P. Rota, M. Oberste, S. Monroe, W. Nix, R. Campagnoli et al., Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome, Science, vol.300, issue.5624, pp.1394-1399, 2003.
DOI : 10.1126/science.1085952

H. Riski and T. Hovi, Coronavirus infections of man associated with diseases other than the common cold, Journal of Medical Virology, vol.1, issue.3, pp.259-265, 1980.
DOI : 10.1002/jmv.1890060309

S. Forgie and T. Marrie, Healthcare-Associated Atypical Pneumonia, Seminars in Respiratory and Critical Care Medicine, vol.30, issue.01, pp.67-85, 2009.
DOI : 10.1055/s-0028-1119811

E. Yeh, A. Collins, M. Cohen, P. Duffner, and H. Faden, Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis, Pediatrics, vol.113, pp.73-76, 2004.

A. Bonavia, N. Arbour, V. Yong, and P. Talbot, Infection of primary cultures of human neural cells by human coronaviruses 229E and OC43, J. Virol, vol.71, pp.800-806, 1997.

N. Arbour, G. Côté, C. Lachance, M. Tardieu, N. Cashman et al., Acute and persistent infection of human neural cell lines by human coronavirus OC43, J. Virol, vol.73, pp.3338-3350, 1999.

N. Arbour, S. Ekandé, G. Côté, C. Lachance, F. Chagnon et al., Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E, J. Virol, vol.73, pp.3326-3337, 1999.

J. Edwards, F. Denis, and P. Talbot, Activation of glial cells by human coronavirus OC43 infection, Journal of Neuroimmunology, vol.108, issue.1-2, pp.73-81, 2000.
DOI : 10.1016/S0165-5728(00)00266-6

H. Jacomy and P. Talbot, Vacuolating encephalitis in mice infected by human coronavirus OC43, Virology, vol.315, issue.1, pp.20-33, 2003.
DOI : 10.1016/S0042-6822(03)00323-4

N. Arbour, R. Day, J. Newcombe, and P. Talbot, Neuroinvasion by Human Respiratory Coronaviruses, Journal of Virology, vol.74, issue.19, pp.8913-8921, 2000.
DOI : 10.1128/JVI.74.19.8913-8921.2000
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC102086

J. Olney, Neurotoxicity of excitatory amino acids Kainic acid as a tool in neurobiology, pp.95-121, 1978.

L. Mark, R. Prost, J. Ulmer, M. Smith, D. Daniels et al., Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging, AJNR Am. J. Neuroradiol, vol.22, pp.1813-1824, 2001.

J. Aledo, P. Gomez-fabre, L. Olalla, and J. Marquez, Identification of two human glutaminase loci and tissue-specific expression of the two related genes, Mammalian Genome, vol.11, issue.12, pp.1107-1110, 2000.
DOI : 10.1007/s003350010190

E. Kvamme, L. Nissen-meyer, B. Roberg, and I. Torgner, Novel Form of Phosphate Activated Glutaminase in Cultured Astrocytes and Human Neuroblastoma Cells, PAG in Brain Pathology and Localization in the Mitochondria, Neurochemical Research, vol.13, issue.Pt2, pp.1341-1345, 2008.
DOI : 10.1007/s11064-008-9589-9

J. Shijie, H. Takeuchi, I. Yawata, Y. Harada, Y. Sonobe et al., Blockade of Glutamate Release from Microglia Attenuates Experimental Autoimmune Encephalomyelitis in Mice, The Tohoku Journal of Experimental Medicine, vol.217, issue.2, pp.87-92, 2009.
DOI : 10.1620/tjem.217.87

Y. Huang, L. Zhao, B. Jia, L. Wu, Y. Li et al., Glutaminase Dysregulation in HIV-1-Infected Human Microglia Mediates Neurotoxicity: Relevant to HIV-1-Associated Neurocognitive Disorders, Journal of Neuroscience, vol.31, issue.42, pp.15195-15204, 2011.
DOI : 10.1523/JNEUROSCI.2051-11.2011

R. Sattler and M. Tymianski, Molecular mechanisms of calcium-dependent excitotoxicity, Journal of Molecular Medicine, vol.78, issue.1, pp.3-13, 2000.
DOI : 10.1007/s001090000077

S. Tilleux and E. Hermans, Neuroinflammation and regulation of glial glutamate uptake in neurological disorders, Journal of Neuroscience Research, vol.1034, issue.10, pp.2059-2070, 2007.
DOI : 10.1002/jnr.21325

M. Norenberg, Distribution of glutamine synthetase in the rat central nervous system., Journal of Histochemistry & Cytochemistry, vol.27, issue.3, pp.756-762, 1979.
DOI : 10.1177/27.3.39099

M. Norenberg and A. Martinez-hernandez, Fine structural localization of glutamine synthetase in astrocytes of rat brain, Brain Research, vol.161, issue.2, pp.303-3100006, 1979.
DOI : 10.1016/0006-8993(79)90071-4

J. Albrecht, M. Sidoryk-wegrzynowicz, M. Zielinska, and M. Aschner, Roles of glutamine in neurotransmission, Neuron Glia Biology, vol.16, issue.04, pp.263-276, 2010.
DOI : 10.1080/13813450902835690

M. Arundine and M. Tymianski, Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity, Cell Calcium, vol.34, issue.4-5, pp.325-337, 2003.
DOI : 10.1016/S0143-4160(03)00141-6

K. Lees, K. Asplund, A. Carolei, S. Davis, H. Diener et al., Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial, The Lancet, vol.355, issue.9219, pp.1949-1954, 2000.
DOI : 10.1016/S0140-6736(00)02326-6

J. Kemp and R. Mckernan, NMDA receptor pathways as drug targets, Nature Neuroscience, vol.5, issue.Supp, pp.1039-1042, 2002.
DOI : 10.1038/nn936

C. Parsons, A. Stoffler, and W. Danysz, Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse, Neuropharmacology, vol.53, issue.6, pp.699-723, 2007.
DOI : 10.1016/j.neuropharm.2007.07.013

S. Lipton, Failures and successes of NMDA receptor antagonists: Molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults, NeuroRX, vol.18, issue.1211, pp.101-110, 2004.
DOI : 10.1602/neurorx.1.1.101

X. Dong, Y. Wang, and Z. Qin, Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases, Acta Pharmacologica Sinica, vol.339, issue.4, 2009.
DOI : 10.1073/pnas.0709379104

A. Mehta, M. Prabhakar, P. Kumar, R. Deshmukh, and P. Sharma, Excitotoxicity: Bridge to various triggers in neurodegenerative disorders, European Journal of Pharmacology, vol.698, issue.1-3, pp.6-18, 2013.
DOI : 10.1016/j.ejphar.2012.10.032

D. Wilkinson, A review of the effects of memantine on clinical progression in Alzheimer's disease, International Journal of Geriatric Psychiatry, vol.24, issue.9, pp.769-776, 2012.
DOI : 10.1002/gps.2788

M. Starck, H. Albrecht, W. Pollmann, M. Dieterich, and A. Straube, Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin, Journal of Neurology, vol.51, issue.3, pp.322-327, 2010.
DOI : 10.1007/s00415-009-5309-x

M. Emre, M. Tsolaki, U. Bonuccelli, A. Destee, E. Tolosa et al., Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial, The Lancet Neurology, vol.9, issue.10, pp.969-977, 2010.
DOI : 10.1016/S1474-4422(10)70194-0

M. Anitha, M. Nandhu, T. Anju, P. Jes, and C. Paulose, Targeting glutamate mediated excitotoxicity in huntington???s disease: Neural progenitors and partial glutamate antagonist ??? Memantine, Medical Hypotheses, vol.76, issue.1, pp.138-140, 2011.
DOI : 10.1016/j.mehy.2010.09.003

P. Blakely, B. Kleinschmidt-demasters, K. Tyler, and D. Irani, Disrupted Glutamate Transporter Expression in the Spinal Cord With Acute Flaccid Paralysis Caused by West Nile Virus Infection, Journal of Neuropathology & Experimental Neurology, vol.68, issue.10, pp.1061-1072, 2009.
DOI : 10.1097/NEN.0b013e3181b8ba14

I. Cisneros and A. Ghorpade, HIV-1, Methamphetamine and Astrocyte Glutamate Regulation: Combined Excitotoxic Implications for Neuro-AIDS, Current HIV Research, vol.10, issue.5, pp.392-406, 2012.
DOI : 10.2174/157016212802138832

J. Fotheringham, E. Williams, N. Akhyani, and S. Jacobson, Human Herpesvirus 6 (HHV-6) Induces Dysregulation of Glutamate Uptake and Transporter Expression in Astrocytes, Journal of Neuroimmune Pharmacology, vol.66, issue.23, pp.105-116, 2008.
DOI : 10.1007/s11481-007-9084-0

R. Szymocha, H. Akaoka, M. Dutuit, C. Malcus, M. Didier-bazes et al., Human T-Cell Lymphotropic Virus Type 1-Infected T Lymphocytes Impair Catabolism and Uptake of Glutamate by Astrocytes via Tax-1 and Tumor Necrosis Factor Alpha, Journal of Virology, vol.74, issue.14, pp.6433-6441, 2000.
DOI : 10.1128/JVI.74.14.6433-6441.2000

J. Billaud, C. Ly, T. Phillips, and J. De-la-torre, Borna Disease Virus Persistence Causes Inhibition of Glutamate Uptake by Feline Primary Cortical Astrocytes, Journal of Virology, vol.74, issue.22, pp.10438-10446, 2000.
DOI : 10.1128/JVI.74.22.10438-10446.2000

J. Darman, S. Backovic, S. Dike, N. Maragakis, C. Krishnan et al., Viral-Induced Spinal Motor Neuron Death Is Non-Cell-Autonomous and Involves Glutamate Excitotoxicity, Journal of Neuroscience, vol.24, issue.34, pp.7566-7575, 2004.
DOI : 10.1523/JNEUROSCI.2002-04.2004

J. St-jean, M. Desforges, and P. Talbot, Genetic Evolution of Human Coronavirus OC43 in Neural Cell Culture, Adv. Exp. Med. Biol, vol.581, pp.499-502978, 2006.
DOI : 10.1007/978-0-387-33012-9_88

E. Brison, H. Jacomy, M. Desforges, and P. Talbot, Glutamate Excitotoxicity Is Involved in the Induction of Paralysis in Mice after Infection by a Human Coronavirus with a Single Point Mutation in Its Spike Protein, Journal of Virology, vol.85, issue.23, pp.12464-1247305576, 2011.
DOI : 10.1128/JVI.05576-11
URL : https://hal.archives-ouvertes.fr/pasteur-00723278

J. St-jean, M. Desforges, F. Almazan, H. Jacomy, L. Enjuanes et al., Recovery of a Neurovirulent Human Coronavirus OC43 from an Infectious cDNA Clone, Journal of Virology, vol.80, issue.7, pp.3670-3674, 2006.
DOI : 10.1128/JVI.80.7.3670-3674.2006

F. Lambert, H. Jacomy, G. Marceau, and P. Talbot, Titration of Human Coronaviruses Using an Immunoperoxidase Assay, Journal of Visualized Experiments, vol.454, issue.14, pp.93-102978, 2008.
DOI : 10.3791/751
URL : https://hal.archives-ouvertes.fr/pasteur-00819975

H. Jacomy, J. St-jean, E. Brison, G. Marceau, M. Desforges et al., Mutations in the spike glycoprotein of human coronavirus OC43 modulate disease in BALB/c mice from encephalitis to flaccid paralysis and demyelination, Journal of Neurovirology, vol.16, issue.4, pp.279-293, 2010.
DOI : 10.3109/13550284.2010.497806
URL : https://hal.archives-ouvertes.fr/pasteur-00819567

C. Power, T. Moench, J. Peeling, P. Kong, and T. Langelier, Feline immunodeficiency virus causes increased glutamate levels and neuronal loss in brain, Neuroscience, vol.77, issue.4, pp.1175-1185, 1997.
DOI : 10.1016/S0306-4522(96)00531-3

S. Gupta, A. Knight, P. Knapp, K. Hauser, J. Keller et al., HIV-Tat elicits microglial glutamate release: Role of NAPDH oxidase and the cystine???glutamate antiporter, Neuroscience Letters, vol.485, issue.3, pp.233-236, 2010.
DOI : 10.1016/j.neulet.2010.09.019

C. Chen, Y. Ou, C. Chang, H. Pan, S. Liao et al., Glutamate released by Japanese encephalitis virus-infected microglia involves TNF-?? signaling and contributes to neuronal death, Glia, vol.52, issue.3, pp.487-501, 2012.
DOI : 10.1002/glia.22282

M. Desforges, D. Favreau, E. Brison, J. Desjardins, M. Messen-pinard et al., Human coronavirus: respiratory pathogens revisited as infectious neuroinvasive, neurotropic, and neurovirulent agents, Neuroviral infections: RNA viruses and retroviruses, pp.93-121, 2013.

E. Kvamme, B. Roberg, and I. Torgner, Phosphate-activated glutaminase and mitochondrial glutamine transport in the brain, Neurochemical Research, vol.25, issue.9/10, pp.1407-1419, 2000.
DOI : 10.1023/A:1007668801570

S. Hogstad, G. Svenneby, I. Torgner, E. Kvamme, L. Hertz et al., Glutaminase in neurons and astrocytes cultured from mouse brain: Kinetic properties and effects of phosphate, glutamate, and ammonia, Neurochemical Research, vol.42, issue.4, pp.383-388, 1988.
DOI : 10.1007/BF00972489

H. Takeuchi, J. S. Wang, J. Zhang, G. Kawanokuchi, J. Kuno et al., Tumor Necrosis Factor-?? Induces Neurotoxicity via Glutamate Release from Hemichannels of Activated Microglia in an Autocrine Manner, Journal of Biological Chemistry, vol.281, issue.30, pp.21362-21368, 2006.
DOI : 10.1074/jbc.M600504200

N. Danbolt, Glutamate uptake, Progress in Neurobiology, vol.65, issue.1, pp.1-105, 2001.
DOI : 10.1016/S0301-0082(00)00067-8

C. Anderson and R. Swanson, Astrocyte glutamate transport: review of properties,regulation,andphysiologicalfunctions.Glia32:1?14, pp.1098-11362, 2000.

Z. Wang, O. Pekarskaya, M. Bencheikh, W. Chao, H. Gelbard et al., Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120, Virology, vol.312, issue.1, pp.60-73, 2003.
DOI : 10.1016/S0042-6822(03)00181-8

J. Carmen, J. Rothstein, and D. Kerr, Tumor necrosis factor-?? modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitis, Brain Research, vol.1263, pp.143-154, 2009.
DOI : 10.1016/j.brainres.2009.01.040

K. Okada, U. Yamashita, and S. Tsuji, Modulation of Na()-dependent glutamate transporter of murine astrocytes by inflammatory mediators, J. UOEH, vol.27, pp.161-170, 2005.

N. Prow and D. Irani, The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis, Journal of Neurochemistry, vol.417, issue.Suppl, pp.1276-1286, 2008.
DOI : 10.1111/j.1471-4159.2008.05230.x

T. Huang, O. Banion, and M. , Interleukin-1?? and Tumor Necrosis Factor-?? Suppress Dexamethasone Induction of Glutamine Synthetase in Primary Mouse Astrocytes, Journal of Neurochemistry, vol.71, issue.4, pp.1436-1442, 1998.
DOI : 10.1046/j.1471-4159.1998.71041436.x

J. Zou, Y. Wang, F. Dou, H. Lu, Z. Ma et al., Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons, Neurochemistry International, vol.56, issue.4, pp.577-584, 2010.
DOI : 10.1016/j.neuint.2009.12.021

K. Takeda, M. Muramatsu, T. Chikuma, and T. Kato, Effect of Memantine on the Levels of Neuropeptides and Microglial Cells in the Brain Regions of Rats with Neuropathic Pain, Journal of Molecular Neuroscience, vol.288, issue.3, pp.380-390, 2009.
DOI : 10.1007/s12031-009-9224-5

H. Wu, N. Tzeng, L. Qian, S. Wei, X. Hu et al., Novel Neuroprotective Mechanisms of Memantine: Increase in Neurotrophic Factor Release from Astroglia and Anti-Inflammation by Preventing Microglial Activation, Neuropsychopharmacology, vol.12, issue.10, pp.2344-2357, 2009.
DOI : 10.1016/j.neuropharm.2006.08.007

S. Hu, W. Sheng, L. Ehrlich, P. Peterson, and C. Chao, Cytokine Effects on Glutamate Uptake by Human Astrocytes, Neuroimmunomodulation, vol.7, issue.3, pp.153-159, 2000.
DOI : 10.1159/000026433

S. Liao and C. Chen, Differential effects of cytokines and redox potential on glutamate uptake in rat cortical glial cultures, Neuroscience Letters, vol.299, issue.1-2, pp.113-116394001499, 2001.
DOI : 10.1016/S0304-3940(01)01499-9

S. Ackerley, A. Grierson, J. Brownlees, P. Thornhill, B. Anderton et al., Glutamate Slows Axonal Transport of Neurofilaments in Transfected Neurons, The Journal of Cell Biology, vol.1996, issue.1, pp.165-175, 2000.
DOI : 10.1083/jcb.139.5.1307

C. Miller, S. Ackerley, J. Brownlees, A. Grierson, N. Jacobsen et al., Axonal transport of neurofilaments in normal and disease states, Cellular and Molecular Life Sciences CMLS, vol.59, issue.2, pp.323-330, 2002.
DOI : 10.1007/s00018-002-8425-7

T. Shea, W. Chan, J. Kushkuley, and S. Lee, Organizational dynamics, functions, and pathobiological dysfunctions of neurofilaments. Results Probl, Cell Differ, vol.48, pp.29-45, 2009.

L. Schirmer, J. Antel, W. Bruck, and C. Stadelmann, Axonal Loss and Neurofilament Phosphorylation Changes Accompany Lesion Development and Clinical Progression in Multiple Sclerosis, Brain Pathology, vol.50, issue.5, pp.428-440, 2011.
DOI : 10.1111/j.1750-3639.2010.00466.x

I. Tsunoda, L. Kuang, J. Libbey, and R. Fujinami, Axonal Injury Heralds Virus-Induced Demyelination, The American Journal of Pathology, vol.162, issue.4, pp.1259-1269, 2003.
DOI : 10.1016/S0002-9440(10)63922-3

R. Perrot, R. Berges, A. Bocquet, and J. Eyer, Review of the Multiple Aspects of Neurofilament Functions, and their Possible Contribution to Neurodegeneration, Molecular Neurobiology, vol.137, issue.Pt 2, pp.27-65, 2008.
DOI : 10.1007/s12035-008-8033-0

S. Lipton, Pathologically-Activated Therapeutics for Neuroprotection: Mechanism of NMDA Receptor Block by Memantine and S-Nitrosylation, Current Drug Targets, vol.8, issue.5, pp.621-632, 2007.
DOI : 10.2174/138945007780618472

S. Cady, J. Wang, Y. Wu, W. Degrado, and M. Hong, Specific Binding of Adamantane Drugs and Direction of Their Polar Amines in the Pore of the Influenza M2 Transmembrane Domain in Lipid Bilayers and Dodecylphosphocholine Micelles Determined by NMR Spectroscopy, Journal of the American Chemical Society, vol.133, issue.12, pp.4274-4284, 2011.
DOI : 10.1021/ja102581n

D. Ickes, T. Venetta, Y. Phonphok, and K. Rosenthal, Tromantadine inhibits a late step in herpes simplex virus type 1 replication and syncytium formation, Antiviral Research, vol.14, issue.2, pp.75-850166, 1990.
DOI : 10.1016/0166-3542(90)90045-9

J. Tanner, B. Zheng, J. Zhou, R. Watt, J. Jiang et al., The Adamantane-Derived Bananins Are Potent Inhibitors of the Helicase Activities and Replication of SARS Coronavirus, Chemistry & Biology, vol.12, issue.3, pp.303-311, 2005.
DOI : 10.1016/j.chembiol.2005.01.006

A. Bukrinskaya, N. Vorkunova, and R. Narmanbetova, Rimantadine hydrochloride blocks the second step of influenza virus uncoating, Archives of Virology, vol.38, issue.3, pp.275-282, 1980.
DOI : 10.1007/BF01314742

M. Takeda, A. Pekosz, K. Shuck, L. Pinto, and R. Lamb, Influenza A Virus M2 Ion Channel Activity Is Essential for Efficient Replication in Tissue Culture, Journal of Virology, vol.76, issue.3, pp.1391-1399, 2002.
DOI : 10.1128/JVI.76.3.1391-1399.2002

K. Rosenthal, M. Sokol, R. Ingram, R. Subramanian, and R. Fort, Tromantadine: inhibitor of early and late events in herpes simplex virus replication., Antimicrobial Agents and Chemotherapy, vol.22, issue.6, pp.1031-1036, 1982.
DOI : 10.1128/AAC.22.6.1031

A. Tselis, Evidence for Viral Etiology of Multiple Sclerosis, Seminars in Neurology, vol.31, issue.03, pp.307-316, 2011.
DOI : 10.1055/s-0031-1287656

W. Grant, A. Campbell, R. Itzhaki, and J. Savory, The significance of environmental factors in the etiology of Alzheimer's disease, Journal of Alzheimer's Disease, vol.4, issue.3, pp.179-189, 2002.
DOI : 10.3233/JAD-2002-4308

S. Tisch and B. Brew, HIV, HAART, and Parkinson's disease: Co-incidence or pathogenetic link?, Movement Disorders, vol.25, issue.13, pp.2257-2258, 2010.
DOI : 10.1002/mds.23277

M. Ison, Clinical use of approved influenza antivirals: therapy and prophylaxis, Influenza and Other Respiratory Viruses, vol.353, issue.6 Suppl 1, pp.7-13, 2013.
DOI : 10.1111/irv.12046

C. Fett, M. Dediego, J. Regla-nava, L. Enjuanes, and S. Perlman, Complete Protection against Severe Acute Respiratory Syndrome Coronavirus-Mediated Lethal Respiratory Disease in Aged Mice by Immunization with a Mouse-Adapted Virus Lacking E Protein, Journal of Virology, vol.87, issue.12, pp.6551-655900087, 2013.
DOI : 10.1128/JVI.00087-13

C. Page, L. Goicochea, K. Matthews, Y. Zhang, P. Klover et al., Induction of Alternatively Activated Macrophages Enhances Pathogenesis during Severe Acute Respiratory Syndrome Coronavirus Infection, Journal of Virology, vol.86, issue.24, pp.13334-1334901689, 2012.
DOI : 10.1128/JVI.01689-12

A. Noçon, J. Ip, R. Terry, S. Lim, D. Getts et al., The Bacteriostatic Protein Lipocalin 2 Is Induced in the Central Nervous System of Mice with West Nile Virus Encephalitis, Journal of Virology, vol.88, issue.1, pp.2094-2107, 2013.
DOI : 10.1128/JVI.02094-13

X. Li, Y. Deng, H. Yang, H. Zhao, T. Jiang et al., A Chimeric Dengue Virus Vaccine using Japanese Encephalitis Virus Vaccine Strain SA14-14-2 as Backbone Is Immunogenic and Protective against Either Parental Virus in Mice and Nonhuman Primates, Journal of Virology, vol.87, issue.24, pp.13694-1370500931, 2013.
DOI : 10.1128/JVI.00931-13

K. Mott, M. Zandian, S. Allen, and H. Ghiasi, Role of Interleukin-2 and Herpes Simplex Virus 1 in Central Nervous System Demyelination in Mice, Journal of Virology, vol.87, issue.22, pp.12102-12109, 2013.
DOI : 10.1128/JVI.02241-13

K. Boylan, C. Yang, J. Crook, K. Overstreet, M. Heckman et al., Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker, Journal of Neurochemistry, vol.14, issue.5, pp.1182-1191, 2009.
DOI : 10.1111/j.1471-4159.2009.06386.x